Moderna, Inc. (MRNA)
51.55
-2.02
(-3.77%)
USD |
NASDAQ |
Mar 02, 10:30
Moderna Free Cash Flow : -2.075B for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Gilead Sciences, Inc. | 9.456B |
| Johnson & Johnson | 19.70B |
| Eli Lilly & Co. | 5.964B |
| Merck & Co., Inc. | 12.36B |
| Pfizer Inc. | 9.076B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 930.00M |
| Cash from Investing (Quarterly) | -48.00M |
| Cash from Financing (Quarterly) | 581.00M |
| Free Cash Flow Per Share (Quarterly) | 2.273 |
| Free Cash Flow to Equity (Quarterly) | 320.00M |
| Free Cash Flow to Firm (Quarterly) | 899.27M |
| Free Cash Flow Yield | -10.35% |